NLRP3 and infection: Therefore, inhibiting the overproduction of ROS, preventing NLRP3 inflammasome activation, and subsequently suppressing the cleavage of GSDMD due to caspase-1 activation, thereby reducing the release of cytokines such as IL-1β and IL-18, can have a protective effect against severe infection-induced fatal inflammatory diseases.